Skip to main content
Premium Trial:

Request an Annual Quote

Report Forecasts Proteomics Market at $2.68B in 2008

NEW YORK, Aug 15 - A new study of the proteomics market forecasts that the market would grow to $2.68 billion in 2008, from $1.52 billion in 2003-a less bold projection than that of a report by the same firm in 2001.


The report, by Front Line Strategic Management Consulting, predicts that the proteomics market will grow at a 12 percent overall compound annual growth trate for the next five years. Currently, the report says, protein separation has 51 percent of the market share for proteomics revenues, with the remainder being occupied by protein characterization, content and informatics; and services.


Additionally, Front Line's analysts see the geographic breakdown of the current market being 45 percent in the US, 40 percent in Europe, and 10 percent in Japan.


The report predicts that proteomics will find future applications in agriculture, biodefense, clinical diagnostics, gene therapy, and oncology.


A June 2001 proteomics market forecast by Frontline predicted that the proteomics market would increase from a $561-million market to a $2.8 billion market by 2005. 


Another forecast, released by Frost & Sullivan in August 2001 was even more rosy, putting the proteomics market at $5.6 billion by 2006.


The current report sells for $5,100.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.